Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Daniel Vitt Insider Profile
18 Followers
Daniel Vitt, CEO and Director, Director at Immunic, holds 390.88K shares in Immunic (Ticker: IMUX). Most recently, Daniel Vitt Bought $14,000 shares of Immunic on Feb 28, 2024 for an estimated value of 18.20K.
Daniel Vitt Immunic (IMUX)CEO and Director, Director
Immunic (IMUX)
CEO and Director, Director
Ranked #87,566 out of 100,202 Corporate Insiders
Profitable Transactions
0 out of 4 Profitable Transactions
Average Return
-37.00%
Average return per transaction
Time Frame
Compare to
Insider Roles
CEO and Director, Director
Roles that Daniel Vitt holds in companies
Most Profitable Insider Trade
The most profitable trade made by Daniel Vitt
Daniel Vitt's Trading History
List of latest transactions for each holding click on a transaction to see Daniel Vitt's performance on stock
You May Also Like
Daniel Vitt insider profile FAQ
What is the percentage of profitable transactions made by Daniel Vitt?
The percentage of profitable transactions made by Daniel Vitt is 0%.
What is the average return per transaction made by Daniel Vitt?
The average return per transaction made by Daniel Vitt is -37.00%.
What stocks does Daniel Vitt hold?
Daniel Vitt holds: IMUX stocks.
What was Daniel Vitt’s latest transaction?
Daniel Vitt latest transaction was an Informative Buy of $18.20K.
What was Daniel Vitt's most profitable transaction?
Daniel Vitt’s most profitable transaction was an Informative Buy of IMUX stock on November 23, 2022. The return on the trade was -22.70%.
What is Daniel Vitt's role in Immunic?
Daniel Vitt's role in Immunic is CEO and Director, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.